Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

20,445 total articles

Akari Therapeutics Announces Strategic Partnership with WuXi XDC to Advance Development of Its Novel ADC Payload Targeting RNA Splicing

Akari Therapeutics Announces Strategic Partnership with WuXi XDC to Advance Development of Its Novel ADC Payload Targeting RNA Splicing

Akari Therapeutics announced a strategic partnership with WuXi XDC to accelerate development of its novel PH1 payload, an RNA splicing modulating antibody drug conjugate (ADC) currently being developed for metastatic urothelial cancer. The collaboration aims to fast-track the first-in-human clinical trial of Akari's lead candidate AKTX-101, leverag…

Diamondback Energy, Inc. Announces Launch of Tender Offers for Any and All of its Outstanding 4.400% Senior Notes due 2051 and 4.250% Senior Notes due 2052

Diamondback Energy, Inc. Announces Launch of Tender Offers for Any and All of its Outstanding 4.400% Senior Notes due 2051 and 4.250% Senior Notes due 2052

Diamondback Energy, Inc., a NASDAQ-listed independent oil and natural gas company, has commenced tender offers to repurchase all outstanding 4.400% Senior Notes due 2051 and 4.250% Senior Notes due 2052 for cash. The offers, expiring April 10, 2026, allow holders to tender notes for purchase with accrued interest, subject to terms outlined in the O…

Nexxen Launches AI-Native DSP UI, with Major Enhancements to the nexAI DSP Assistant to Amplify Full-Funnel Outcomes

Nexxen Launches AI-Native DSP UI, with Major Enhancements to the nexAI DSP Assistant to Amplify Full-Funnel Outcomes

Nexxen has launched a new AI-native user interface for its demand-side platform (DSP) along with major enhancements to its nexAI DSP Assistant. These upgrades extend the assistant's capabilities to include pre-campaign setup, troubleshooting, and mid-campaign optimization while maintaining user control and transparency. The AI-driven improvements a…

OceanFirst Financial Corp. and Flushing Financial Corporation Announce Receipt of the Requisite Shareholder Approvals for Pending Merger Transaction

OceanFirst Financial Corp. and Flushing Financial Corporation Announce Receipt of the Requisite Shareholder Approvals for Pending Merger Transaction

OceanFirst Financial Corp. and Flushing Financial Corporation announced that they have obtained the necessary shareholder and regulatory approvals to proceed with their previously agreed merger. The transaction has already received approvals from the New York State Department of Financial Services and the Office of the Comptroller of the Currency. …

AtlasClear Holdings Begins Onboarding of Third Correspondent Broker-Dealer and Executes Clearing Agreement with Fourth Correspondent Broker-Dealer Through Wilson-Davis

AtlasClear Holdings Begins Onboarding of Third Correspondent Broker-Dealer and Executes Clearing Agreement with Fourth Correspondent Broker-Dealer Through Wilson-Davis

AtlasClear Holdings announced the onboarding of a third correspondent broker-dealer to its clearing platform via its subsidiary Wilson-Davis and executed a clearing agreement with a fourth introducing broker-dealer. The company has enhanced its clearing infrastructure, shortened onboarding times, expanded operations staff, and demonstrated scalabil…

TalentAlly, a Subsidiary of Professional Diversity Network, Inc., Launches Next-Generation Career Fair Hiring Platform Powered by ByteCompute.ai

TalentAlly, a Subsidiary of Professional Diversity Network, Inc., Launches Next-Generation Career Fair Hiring Platform Powered by ByteCompute.ai

Professional Diversity Network, Inc. (Nasdaq: IPDN) announced that its subsidiary, TalentAlly, has launched a next-generation virtual hiring platform powered by ByteCompute.ai. The platform offers advanced features such as pre-event candidate targeting, real-time multi-channel engagement, and comprehensive analytics to improve recruiting outcomes a…

The Oncology Institute Names Minh Merchant Chief Legal Officer

The Oncology Institute Names Minh Merchant Chief Legal Officer

The Oncology Institute, a publicly traded oncology care provider, announced the hiring of Minh Merchant as Chief Legal Officer. Merchant brings over 20 years of healthcare legal expertise to oversee the company's legal, regulatory, compliance, and privacy functions, supporting its expansion as a leading value-based oncology group serving approximat…

Oncolytics Biotech® Announces Type C FDA Meeting to Discuss Single-arm Registrational Pathway for Pelareorep in Anal Cancer

Oncolytics Biotech® Announces Type C FDA Meeting to Discuss Single-arm Registrational Pathway for Pelareorep in Anal Cancer

Oncolytics Biotech Inc. announced a scheduled Type C meeting with the FDA to discuss a potential registrational single-arm pivotal study evaluating pelareorep combined with checkpoint inhibitors in second-line and later squamous cell anal carcinoma (SCAC) patients. This study aims to support full approval using objective response rate as the primar…

OneMedNet Announces Strong 2025 Financials and Advances AI-Driven iRWD™ powered by Palantir Foundry enabling Conversational Search on Real-Time Medical Data

OneMedNet Announces Strong 2025 Financials and Advances AI-Driven iRWD™ powered by Palantir Foundry enabling Conversational Search on Real-Time Medical Data

OneMedNet Corporation announced robust financial results for 2025, including a 329% year-over-year revenue increase driven by its AI-driven iRWD™ platform powered by Palantir Foundry. The company has reduced total liabilities by 74%, improved its equity position significantly, and secured promising pilot and subscription opportunities, projecting s…

Q1 2026: Strong Revenue Growth and Therapeutics Pipeline Advancement

Q1 2026: Strong Revenue Growth and Therapeutics Pipeline Advancement

Telix Pharmaceuticals Limited announced robust Q1 2026 financial results with 24% year-over-year revenue growth to $230 million and confirmed FY 2026 guidance between $950 million and $970 million. The company highlighted progress in its therapeutic pipeline, including successful completion of key safety objectives for its TLX591-Tx prostate cancer…

Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Celldex Therapeutics has closed its underwritten public offering of common stock, including full exercise of underwriters’ option, resulting in gross proceeds of approximately $345 million. The offering was conducted under an existing shelf registration with the SEC. The funds are aimed to support the advancement of Celldex's clinical-stage pipelin…

Jena Acquisition Corporation II Announces Non-Compliance with Section 802.01B of the NYSE Listed Company Manual which Requires the Company to Maintain a Minimum of 300 Public Stockholders

Jena Acquisition Corporation II Announces Non-Compliance with Section 802.01B of the NYSE Listed Company Manual which Requires the Company to Maintain a Minimum of 300 Public Stockholders

Jena Acquisition Corporation II, a US-listed blank check company on the NYSE, announced it is currently non-compliant with the NYSE's minimum public stockholder requirement of 300 shareholders. The company plans to submit a business plan to return to compliance within 18 months primarily by completing a de-SPAC transaction. During the cure period, …

Wix Announces Final Results of Modified Dutch Auction Tender Offer

Wix Announces Final Results of Modified Dutch Auction Tender Offer

Wix.com Ltd. successfully concluded its modified Dutch auction tender offer, purchasing 17.58 million shares (29.7% of outstanding shares) at $92.00 per share for approximately $1.617 billion. This substantial share buyback highlights the company's confidence in its long-term strategy and commitment to returning value to shareholders amid ongoing d…

ArcelorMittal has published a convening notice for its Annual General Meeting and Extraordinary General Meeting of shareholders to be held on 5 May 2026

ArcelorMittal has published a convening notice for its Annual General Meeting and Extraordinary General Meeting of shareholders to be held on 5 May 2026

ArcelorMittal has issued a convening notice for its Annual General Meeting and Extraordinary General Meeting on May 5, 2026. Key agenda items include the re-election of current board members, the nomination of a new director, Mr. Roy Harvey, former President and CEO of Alcoa, and renewal of board authorization to issue and cancel shares. Relevant d…